Cargando…
Meta-Analysis of Randomized Controlled Trials on the Efficacy of Di'ao Xinxuekang Capsule and Isosorbide Dinitrate in Treating Angina Pectoris
Objective. Randomized controlled trials (RCTs) on di'ao xinxuekang capsule (XXK) in treating angina pectoris were published only in Chinese and have not been systematically reviewed particularly for comparing XXK with isosorbide dinitrate (ISDN). This study aims to provide a comprehensive PRISM...
Autores principales: | Jia, Yongliang, Chen, Cong, Ng, Choi-San, Leung, Siu-Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310218/ https://www.ncbi.nlm.nih.gov/pubmed/22474528 http://dx.doi.org/10.1155/2012/904147 |
Ejemplares similares
-
Di’ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway
por: Liang, Jiyi, et al.
Publicado: (2022) -
Targeting Energy Protection as a Novel Strategy to Disclose Di’ao Xinxuekang against the Cardiotoxicity Caused by Doxorubicin
por: Wang, Tao, et al.
Publicado: (2023) -
Di’ao Xinxuekang Capsule, a Chinese Medicinal Product, Decreases Serum Lipids Levels in High-Fat Diet-Fed ApoE(–/–) Mice by Downregulating PCSK9
por: Qu, Liping, et al.
Publicado: (2018) -
Comparative Effectiveness of Di'ao Xin Xue Kang Capsule and Compound Danshen Tablet in Patients With Symptomatic Chronic Stable Angina
por: Yu, Yanan, et al.
Publicado: (2014) -
Higher than recommend dosage of sublingual isosorbide dinitrate for treating angina pectoris: a case report and review of the literature
por: Cao, Hong-Yan, et al.
Publicado: (2021)